Baidu Ventures was among the participants in diagnostics technology developer Sherlock Biosciences' series A round, which has closed at $31m.
US-based molecular diagnostics technology developer Sherlock Biosciences completed a $31m series A round on Tuesday following a $13.5m extension featuring Baidu Ventures, a corporate venturing subsidiary of internet group Baidu.
Non-profit group Open Philanthropy Project and venture capital firm Northpond Ventures also took part in the round, alongside unnamed additional investors.
Sherlock formally launched last month with an initial $17.5m in series A funding from investors including Open Philanthropy Project, alongside $17.5m in non-dilutive grant funding.
The company is developing…
